Epigallocatechin-3-Gallate: The Prospective Targeting of Cancer Stem Cells and Preventing Metastasis of Chemically-Induced Mammary Cancer in Rats

American Journal of the Medical Sciences

Volumn 354, Issue 1, 2017, Pages 54-63

  Abd El Rahman, Sahar S ^a   Shehab, Gehan ^b   Nashaat, Heba ^b  

^a Cairo University   (Egypt)

^b ANIMAL HEALTH RESEARCH INSTITUTE   (Egypt)

Author keywords

Antioxidant; Cancer stem cells; CD44; Epigallocatechin gallate; Ki 67; Mammary tumor

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CARCINOGEN; CATECHIN; EPIGALLOCATECHIN GALLATE;

ANALOGS AND DERIVATIVES; ANIMAL; CANCER STEM CELL; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; RAT; SECONDARY; SPRAGUE DAWLEY RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CATECHIN; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85027404480     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1016/j.amjms.2017.03.001     Document Type: Article

References (49)

1. Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2012. CA Cancer J Clin 62 (2012), 10–29 [PubMed: 22237781].
2. Chung, S.S., Vadgama, J.V., Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. Anticancer Res 35:1 (2015), 39–46.
3. Rathone, K., Wang, H.C., Mesenchymal and stem-like cell targeting in suppression of chronically induced breast carcinogenesis. Cancer Lett 333 (2013), 113–123 [PubMed: 23352646].
4. Mukhtar, H., Ahmad, N., Green tea in chemoprevention of cancer. Toxicol Sci 52 (1999), 111–117.
5. Kono, S., Ikeda, M., Tokudome, S., et al. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn. J Can Res 79 (1988), 1067–1074.
6. Rogers, A.E., Hafer, L.J., Iskander, Y.S., et al. Black tea and mammary gland carcinogenesis by 7, 12-dimethylbenz [a] anthracene in rats fed control or high fat diets. Carcinogenesis 19 (1998), 1269–1273, 10.1093/Carcin/19.7.1269.
7. Katiyar, S.K., Mukhtar, H., Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int J Oncol 8 (1996), 221–238.
8. Yang, C.S., Lambert, J.D., Sang, S., Antioxidative and anticarcinogenic activities of tea polyphenols. Arch Toxicol 83 (2009), 11–21, 10.1007/s00204-008-0372-0.
9. Singh, B.N., Shankar, S., Srivasta, R.K., Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82 (2011), 1807–1821, 10.1016/j.bcp.2011.07.093.
10. Chen, C., Shen, G., Hebbar, V., et al. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24 (2003), 1369–1378.
11. Qanungo, S., Das, M., Haldar, S., et al. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 26 (2005), 958–967.
12. Bettuzzi, S., Brausi, M., Rizzi, F., et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high grade prostate intraepithelial neoplasia: a preliminary report from one-year proof-of-principle study. Cancer Res 66 (2006), 1234–1240, 10.1158/0008-5472.CAN-05-1145.
13. Otsuka, T., Ogo, T., Eto, T., et al. Growth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green tea. Life Sci. 63:16 (1998), 1397–1403.
14. Whitsett, T., Carpenter, M., Lamartiniere, C.A., Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. Carcinogenesis, 5, 2006, 15, 10.1186/1477-3163-5-15.
15. Luo, T., Wang, J., Yin, Y., et al. Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res, 12(1), 2010, R8, 10.1186/bcr2473.
16. Satoh, K., Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta 90:1 (1978), 37–43.
17. Aebi, H., Catalase in vitro. Method Enzymol 105 (1984), 121–126.
18. Beutler, E., Duron, O., Kellin, B.M., Improved method for the determination of blood glutathione. J Lab Clin Med 61 (1963), 882–888.
19. Bancroft, J.D., Gamble, M., Theory and Practice of Histological Techniques, 6th ed., 2008, Elsevier, Churchill Livingstone, China.
20. Russo, J., Russo, I.H., Rogers, A.E., et al. Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the mammary gland. IARC Sci Publ 99 (1990), 47–78.
21. Hsu, S.M., Raine, L., Fanger, H., The use of antiavidin antibody and avidin-biotin peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75 (1981), 816–821.
22. Chan, Y.H., Biostatistics301: repeated measurement analysis. Singapore Med J 45:8 (2004), 354–369.
23. Kavanagh, K.T., Hafer, L.J., Kim, D.W., et al. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 82 (2001), 387–398.
24. Benakanakere, I., Besch-Williford, C., Carroll, C.E., et al. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz (a) anthracene-induced mammary tumors in Sprague-Dawley rats. Cancer Prev Res (Phila) 3:9 (2010), 1157–1167, 10.1158/1940-6207.
25. Feng, M., Feng, C., Yu, Z., et al. Histopathological alterations during breast carcinogenesis in a rat model induced by 7,12-dimethylbenz (a) anthracene and estrogen-progestogen combinations. Int J Clin Exp Med 8:1 (2015), 346–357.
26. Mineva, N.D., Paulson, K.E., Naber, S.P., et al. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells. PLoS One 8:9 (2013), 1–14, 10.1371/journal.pone.0073464.
27. Shankar, S., Ganapathy, S., Srivastava, R.K., Green tea polyphenols: biology and therapeutic implications in cancer. Front Biosci 12 (2007), 4881–4899.
28. Sakata, M., Ikeda, T., Imota, S., et al. Prevention of mammary carcinogenesis inc3H/ouj mice by green tea and tamoxifen. Asian Pac J Cancer Prev 12:2 (2011), 567–571.
29. Braicu, C., Gherman, C.D., Irimie, A., et al. Epigallocatechin-3-gallate (EGCG) inhibit cell proliferation and migratory behavior of triple negative breast cancer cells. J nanosci Nanotechnal 13 (2013), 632–637.
30. Gu, J.W., Makey, K.L., Tucker, K.B., et al. EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression. Vasc Cell, 5(1), 2013, 9, 10.1186/2045-824X-5-9.
31. Li, M.J., Yin, Y.C., Wang, J., et al. Green tea compounds in breast cancer prevention and treatment. World J Clin Oncol 5:3 (2014), 520–528.
32. Jankun, J., Selman, S.H., Swiercz, R., et al. Why drinking green tea could prevent cancer. Nature, 387, 1997, 561, 10.1038/42381.
33. Garbisa, S., Sartor, L., Biggin, S., et al. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91:4 (2001), 822–832.
34. Zhang, G., Miura, Y., Yagasaki, K., Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett 159 (2000), 169–173.
35. Fidler, I.J., Ellis, L.M., The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79 (1994), 185–188.
36. Holmgren, L., O'Reilly, M.S., Folkman, J., Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:2 (1995), 149–153.
37. Nonaka, Y., Iwagaki, H., Kimura, T., et al. Effect of reactive oxygen intermediates on the in vitro invasive capacity of tumor cells and liver metastasis in mice. Int J Cancer 54 (1993), 983–986.
38. Lambert, J.D., Elias, R.J., The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophy 501 (2010), 65–72.
39. Alcaraz, M., Armero, D., Martínez-Beneyto, Y., et al. Chemical genoprotection: reducing biological damage to as low as reasonably achievable levels. Dentomaxillofac Radiol 40 (2011), 310–314, 10.1259/dmfr/95408354].
40. Li, Y., Kong, D., Wang, Z., et al. Regulation of microRNA by natural agents: an emerging field in chemoprevention and chemotherapy research. PharmRes 27 (2010), 1027–1041, 10.1007/s11095-010-0105-y.
41. Wang, Z., Li, Y., Ahmad, A., et al. Targetung miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat 13 (2010), 109–118, 10.1016/j.drup.2010.07.001.
42. Oliveras-Ferraros, C., Vazquez-Martin, A., Colomer, R., et al. Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling. Int J Oncol 32:1 (2008), 113–120.
43. Naujokat, C., Laufer, S., Targeting cancer stem cells with defined compounds and drug. J Can Res 2 (2013), 36–67.
44. Yu Steven, S., Spicer, D.V., Hawes, D., et al. Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients. Front Oncol, 3, 2013, 298.
45. Alshatwi, A.A., Catechin hydrate suppresses MCF-7 proliferation through TP53/caspase-mediated apoptosis. J Exp Clin Cancer Res, 29, 2010, 167.
46. Dean, M., Fojo, T., Bates, S., Tumor stem cells and drug resistance. Nat Rev Cancer 5 (2005), 275–284.
47. Mei, Y., Wei, D., Liu, J., Reversal of cancer multidrug resistance by tea polyphenol in KB cells. J Chemother 15 (2003), 260–265.
48. Kawasaki, B.T., Hurt, E.M., Mistree, T., et al. Targeting cancer stem cells with phytochemicals. Mal interv 8 (2008), 174–184.
49. Tang, S.N., Singh, C., Nall, D., et al. The dietary bioflavonoid quercetin synergizes with epigallocatechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal, 5, 2010, 14, 10.1186/1750-2187-5-14.